Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized dutch gastric cancer group trial [1]

Journal of Clinical Oncology

Volumn 23, Issue 23, 2005, Pages 5404-5405

  Schwarz, Roderich E ^a   Smith, David D ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; LETTER; LYMPH NODE DISSECTION; LYMPHADENECTOMY; METASTASIS; MORBIDITY; PANCREAS RESECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPLENECTOMY; STOMACH CANCER; ADENOCARCINOMA; GASTRECTOMY; MORTALITY; NOTE; POSTOPERATIVE COMPLICATION; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; PANCREATECTOMY; POSTOPERATIVE COMPLICATIONS; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 23944521846     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.189     Document Type: Letter

References (8)

1. Hartgrink HH, van de Velde CJ, Putter H, et al: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22:2069-2077, 2004
2. Degiuli M, Sasako M, Ponti A, et al: Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 16:1490-1493, 1998
3. Lewis WG, Edwards P, Barry JD, et al: D2 or not D2? The gastrectomy question. Gastric Cancer 5:29-34, 2002
4. Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516-524, 1984
5. Hannan EL, Radzyner M, Rubin D, et al: The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 131:6-15, 2002
6. Schwarz RE, Zagala-Nevarez K: Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394-400, 2002
7. Brennan MF: Lymph-node dissection for gastric cancer. N Engl J Med 340:956-958, 1999
8. Schwarz RE, Schwarz RR, Smith DD: Reliability of gastric cancer staging by numeric lymph node examination: Prognostic impact and postoperative therapy implications. ASCO Gastrointestinal Cancers Symposium, San Francisco, CA, January 22-24, 2004 (abstr 4)